Ignite Creation Date:
2024-05-05 @ 11:43 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00110149
Status:
TERMINATED
Last Update Posted:
2017-11-21
First Post:
2005-05-03
Brief Title:
Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkins Lymphoma
Sponsor:
Beth Israel Deaconess Medical Center
Organization:
Beth Israel Deaconess Medical Center
Organization Data
Organization:
Beth Israel Deaconess Medical Center
Class:
OTHER
Study ID:
2004P000044
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Beth Israel Deaconess Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Robin Joyce
Responsible Party Title:
Assistant Professor of Medicine
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Beth Israel Deaconess Medical Center
Old Name:
None
Old Organization:
None